Cellectis is a clinical-stage biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells. Cellectis is focused on addressing the medical and food needs of an ever-growing global population through the use of proprietary gene-editing technologies.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.